Education
About Us
Working with TipRanks
Follow Us
John S. Montalbano Insider Profile
4 Followers
John S. Montalbano, Director at AbCellera Biologics, holds 151.00K shares in AbCellera Biologics (Ticker: ABCL). Most recently, John S. Montalbano Bought $60,000 shares of AbCellera Biologics on Mar 07, 2025 for an estimated value of 140.40K.
John S. Montalbano AbCellera Biologics (ABCL)Director
AbCellera Biologics (ABCL)
Director
Ranked #84,911 out of 100,516 Corporate Insiders
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-27.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of John S. Montalbano's holdings
Insider Roles
Director
Roles that John S. Montalbano holds in companies
Most Profitable Insider Trade
The most profitable trade made by John S. Montalbano
John S. Montalbano's Trading History
List of latest transactions for each holding click on a transaction to see John S. Montalbano's performance on stock
You May Also Like
John S. Montalbano insider profile FAQ
What is the percentage of profitable transactions made by John S. Montalbano?
The percentage of profitable transactions made by John S. Montalbano is 0%.
What is the average return per transaction made by John S. Montalbano?
The average return per transaction made by John S. Montalbano is -27.00%.
What stocks does John S. Montalbano hold?
John S. Montalbano holds: ABCL stocks.
What was John S. Montalbano’s latest transaction?
John S. Montalbano latest transaction was an Informative Buy of $140.40K.
What was John S. Montalbano's most profitable transaction?
John S. Montalbano’s most profitable transaction was an Informative Buy of ABCL stock on March 4, 2022. The return on the trade was -1.70%.
What is John S. Montalbano's role in AbCellera Biologics?
John S. Montalbano's role in AbCellera Biologics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.